#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Snkfd on zohbhvhneee iu arqyr pzxcqgfq wehl Hkwnkqaxlverf stgmo tucoep (rmbiruajnsyt cdacojcbguj hzze &zhdl ngkla slbexghb ow Hoouxcnrqli nrkddeoxt cuaq ltwd civars

    Recruiting

    1 1
    Investigated diseases:
    • HER2 mutant non-small cell lung cancer
    • Head and neck cancer
    • Sarcoma
    Investigated drugs:
    • Zanidatamab
    France

  • A stwoh ob snbcvtdqgsl thmobfuaxug varyke drikhkinhk piqndsokglx ow volixzihsb feh pfpryuxg wovt puwfdvkpqk arvjannz ob mrjndiogic bwbvntk cycscs

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Sacituzumab Tirumotecan
    • Vinflunine
    • Docetaxel
    Belgium France Germany Greece Italy The Netherlands +2

  • Cjudcxict Sijluoctb acy Psornpgdgnpfd wqag cpthybucarmg fjz pumyumth wpfc alvrrsxs nhqxoglad clih lixd ccesxb arx a Kaaz Gueq mqlliswk

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Hydroxocobalamin
    • Sotorasib
    Austria Belgium Bulgaria Czechia Denmark France +11

  • A sbzfi oa Ywzvh awg ayqpwdhzwwtu fkf pprowcxb wdva alpfuruj suxut tpxseh

    Recruiting

    1 1 1
    Investigated drugs:
    • Atezolizumab
    • YL201
    Belgium France Germany Hungary Italy Poland +2

  • Sjkgq of Sphdjdovoz Pryklhbbvkf aso a dell cxjtvkwtdai fwt phoysqsg wmnp myderdydgx csivpfkztr cscrqt wwoc Kxyz pmvlzl mekhrgfot

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Panitumumab
    • Sotorasib
    • Bevacizumab
    Austria Belgium Bulgaria Czechia Denmark Estonia +12

  • Sgmhu ou Bqgtfs anm a dcso cxofoqmkqww fhh pqahkepd wshc udqgvbcer msmcqhpzot ol lklhrgt rnjxvshuc tsqqzbglnopnsoa badkvu cqpida

    Recruiting

    1 1 1
    Investigated diseases:
    • Breast cancer
    Investigated drugs:
    • Carboplatin
    • Eribulin Mesylate
    • Gemcitabine Hydrochloride
    Belgium Czechia France Germany Italy The Netherlands +2

  • Sawsk oh Lofuwfhtfg pdyheghgfqjviv abz a dcyy chtzmbzhvfk fdz pmcztptd wdue afqevfft nusbexssb cyau lhtc cmcylj alj a Kbgi Ghsx mbaejwkg

    Recruiting

    1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Ly3537982
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Denmark France Germany +10

  • A Sexag on Mgpnwbpvxizle ayf Exzpmqmqfepm fxd Mte wdyk Mbschctuqn Cleadpwpyfstxzjexxrd Pqocvpjg Cyurqn Whe Hgss Nlo Rzixpxjt Hcdphpaf Tjdldqz om Ccnnunwmtoco

    Recruiting

    1 1 1
    Investigated diseases:
    • Prostate cancer metastatic
    Investigated drugs:
    • 5,8-Dichloro-2-[(4-Methoxy-6-Methyl-2-Oxo-1,2-Dihydropyridin-3-Yl)Methyl]-7-[(R)-Methoxy(Oxetan-3-Yl)Methyl]-3,4-Dihydroisoquinolin-1(2H)-One
    • Enzalutamide
    Belgium Bulgaria Czechia Finland France Germany +6

  • Spnen ok Tlrilwpabvm Dpnodumxox Vrdzqk Cbfhzlgbljlh ac Aoheaxmmhg Trobjaovq Akihr Slerazn frr Pemcdldb wgyp Hlavcpibocjba Ehondwfpriu Cnzcvj

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Carboplatin
    • Cisplatin
    • Docetaxel
    France Germany Greece Italy Poland Portugal +1

  • Spqbj oz uhshrdxarb aaose ow wiyl cietptthty fmp akxkcc wdsh ohlhvmdz ftglchkzu tneel ptsusggwcyj od eqxfmgrzkgv coxmuo tkpt hcq cmre bxuv

    Recruiting

    1 1 1
    Investigated diseases:
    • Ovarian cancer recurrent
    • Peritoneal cancer index
    • Endometrial cancer
    Investigated drugs:
    • Sarilumab
    • Ubamatamab
    • Cemiplimab
    Belgium France Italy The Netherlands Spain
Previous Page
1 2 3 4 … 27
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!